Big Data Clinical Trials Life Science Regulation 
Drug Discovery World
JULY 11, 2023
Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?
ACRP blog
APRIL 5, 2023
AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
APRIL 4, 2023
In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.
Drug Discovery World
FEBRUARY 6, 2024
As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.”
pharmaphorum
MAY 25, 2021
One of the main reasons to use RWE is to counter a common criticism of the large phase 3 trials that for so long have been the ‘gold standard’ when developing drugs and gaining authorisations from regulators. The post AI, big data and real world evidence – the challenges and opportunities appeared first on. About Savana.
XTalks
AUGUST 2, 2023
In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The TPO receptor agonist regulates blood platelet production by binding to and activating TPO receptors on megakaryocyte cells and inducing signalling cascades that increase platelet production.
pharmaphorum
MARCH 16, 2021
Technologies such as Savana are helping companies augment clinical trials and take a deeper dive into information to extract insights that were previously inaccessible. There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano.
Expert insights. Personalized for you.
40 
Let's personalize your content